Cross-ancestry genome-wide association study and systems-level integrative analyses implicate new risk genes and therapeutic targets for depression
- 24 February 2025
- journal article
- research article
- Published by Springer Nature in Nature Human Behaviour
- Vol. 9 (4) , 806-823
Abstract
Deciphering the genetic architecture of depression is pivotal for characterizing the associated pathophysiological processes and development of new therapeutics. Here we conducted a cross-ancestry genome-wide meta-analysis on depression (416,437 cases and 1,308,758 controls) and identified 287 risk loci, of which 49 are new. Variant-level fine mapping prioritized potential causal variants and functional genomic analysis identified variants that regulate the binding of transcription factors. We validated that 80% of the identified functional variants are regulatory variants, and expression quantitative trait loci analysis uncovered the potential target genes regulated by the prioritized risk variants. Gene-level analysis, including transcriptome and proteome-wide association studies, colocalization and Mendelian randomization-based analyses, prioritized potential causal genes and drug targets. Gene prioritization analyses highlighted likely causal genes, including TMEM106B, CTNND1, AREL1 and so on. Pathway analysis indicated significant enrichment of depression risk genes in synapse-related pathways. Finally, knockdown of Tmem106b in mice resulted in depression-like behaviours, supporting the involvement of Tmem106b in depression. Our study identified new risk loci, likely causal variants and genes for depression, providing important insights into the genetic architecture of depression and potential therapeutic targets.Keywords
All Related Versions
This publication has 95 references indexed in Scilit:
- Regulatory Variant rs2535629 in ITIH3 Intron Confers Schizophrenia Risk By Regulating CTCF Binding and SFMBT1 ExpressionAdvanced Science, 2022
- The Genetic Architecture of Depression in Individuals of East Asian AncestryJAMA Psychiatry, 2021
- Delineating the Genetic Component of Gene Expression in Major DepressionBiological Psychiatry, 2021
- Hippocampal Sirtuin 1 Signaling Mediates Depression-like BehaviorBiological Psychiatry, 2016
- Plasma lipidomics reveals potential lipid markers of major depressive disorderAnalytical and Bioanalytical Chemistry, 2016
- Transethnic Genetic-Correlation Estimates from Summary StatisticsThe American Journal of Human Genetics, 2016
- Anxiety, Stress, and Fear Response in Mice With Reduced Endocannabinoid LevelsBiological Psychiatry, 2016
- Mendelian Randomization Analysis With Multiple Genetic Variants Using Summarized DataGenetic Epidemiology, 2013
- Behavioral profile of P2X7 receptor knockout mice in animal models of depression and anxiety: Relevance for neuropsychiatric disordersBehavioural Brain Research, 2009
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodMethods, 2001